Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature

被引:0
|
作者
Noa Kremer
Igor Snast
Efrat Solomon Cohen
Emmilia Hodak
Daniel Mimouni
Moshe Lapidoth
Sigal Mazor
Assi Levi
机构
[1] Rabin Medical Center,Department of Dermatology, Beilinson Hospital
[2] Tel Aviv University,Sackler School of Medicine
[3] Hebrew University-Hadassah Medical Center,Department of Community Dentistry, School of Dental Medicine
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:209 / 216
页数:7
相关论文
共 50 条
  • [31] Bullous pemphigoid: Rituximab to the rescue?
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) : 1089 - 1090
  • [32] Bullous pemphigoid associated with immune checkpoint inhibitor therapy: A systematic review of the literature
    Asdourian, M. S.
    Shah, N.
    Jacoby, T. V.
    Reynolds, K.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B13 - B13
  • [33] The role of tetracycline-nicotinamide in management of bullous pemphigoid: a systematic review of the literature
    Shah, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 63 - 63
  • [34] Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report
    Vico-Alonso, Cristina
    Calleja-Algarra, Alba
    Aragon-Miguel, Raquel
    Sanchez-Velazquez, Alba
    Velasco-Tamariz, Virginia
    Luis Ortiz-Romero, Pablo
    Monsalvez-Honrubia, Veronica
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [35] Serum Biomarkers in Bullous Pemphigoid: A Systematic Review
    Geng, Ryan S. Q.
    Wei, Elizabeth
    Wilken, Bethany
    Sibbald, Ronald G.
    Sibbald, Cathryn
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [36] A Systematic Evaluation of Dupilumab for Bullous Pemphigoid Treatment
    Ye, Shengzhen
    Ling, Guihua
    Chen, Mingling
    DERMATOLOGIC THERAPY, 2024, 2024
  • [37] Bullous Pemphigoid Successfully Treated with Rituximab
    Silva, Nuno
    Costa, Andreia
    Salvador, Fernando
    Serradeiro, Elisa
    ACTA MEDICA PORTUGUESA, 2017, 30 (03): : 243 - +
  • [38] Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities
    De, D.
    Kaushik, A.
    Handa, S.
    Mahajan, R.
    Schmidt, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E469 - E472
  • [39] Omalizumab in the treatment of bullous pemphigoid: A single-center series of 15 cases
    Ferhatoglu, Zeynep Altan
    Yucesoy, Sera Nur
    Ak, Tumay
    Demir, Yusuf
    MEDICINE, 2024, 103 (30)
  • [40] Burden of Disease of Bullous Pemphigoid: A Targeted Literature Review
    Bahloul, Donia
    Dubucq, Hugo
    Thomas, Ryan B.
    Ajith, Athira
    Boss, Jennifer
    Fotheringham, Iain
    Kumichel, Alexandra
    DERMATOLOGY, 2024, 240 (5-6) : 823 - 832